The phenotype and proliferative potential of prostatic epithelial cells, from organogenesis to the development of androgen independent growth, is modulated through interactions with the microenvironment: age and androgenic milieu represent two components of the microenvironment clearly related to human prostate cancer. Perturbation of the homeostatic interactions between stroma and epithelium could represent a major early event in the genesis of prostate cancer and result in dramatic phenotypic plasticity of the epithelial cells. Most prostate cancers demonstrate phenotypic characteristics of secretory epithelial cells, including androgen-dependent growth mediated via androgen-regulated production of growth regulatory factors by prostatic stromal cells. Proliferation and survival of benign and neoplastic prostate epithelial cells is determined by the presence in the microenvironment of members of the insulin-like growth factor family, epidermal growth factor family, TGF-beta family, and HGF and of their cognate receptors on the epithelial membrane, including HGF receptor c-met and the mannose-6-phosphate/IGF ll receptor which binds both TGF-beta1 and IGF-ll. The hypothesis of this proposal is that these microenviromentally-available effectors are critical factors that modulate the neoplastic phenotype of prostate cancer cells throughout tumor progression, including expression of androgen-independent growth. Expression and response of these genes will be evaluated in an androgen-responsive prostate tumor epithelial cell line established from the Dunning H tumor; a stromal cell line established from the same tumor; an androgen-responsive prostate epithelial cell line established from a regenerating prostate and a stromal cell line established from the same regenerating prostate.
The Specific Aims are: (1) Characterize the pattern of basal gene expression, androgen-induced gene expression and gene expression in cocultures of an androgen-responsive rat prostate epithelial cell line, an androgen-responsive neoplastic prostate epithelial cell line established from the Dunning H tumor, and normal and tumor-derived stromal cell lines; (2) Establish whether androgen-independent growth is facilitated by ligand-independent activation of the androgen receptor by microenvironmentally available effector molecules; and (3) Characterize the ability of the in vivo tissue microenvironment, including age effects, to modulate the phenotpye of benign, neoplastic and genetically manipulated prostate epithelial cell lines.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA064865-07
Application #
6172111
Study Section
Special Emphasis Panel (ZRG2-PTHB (01))
Program Officer
Mohla, Suresh
Project Start
1994-09-01
Project End
2003-04-30
Budget Start
2000-05-01
Budget End
2001-04-30
Support Year
7
Fiscal Year
2000
Total Cost
$222,807
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pathology
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Huss, Wendy J; Gray, Danny R; Greenberg, Norman M et al. (2005) Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res 65:6640-50
Huss, Wendy J; Gray, Danny R; Werdin, Eric S et al. (2004) Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model. Prostate 60:77-90
Huss, Wendy J; Gregory, Christopher W; Smith, Gary J (2004) Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: association with tumor cell proliferation prior to recurrence. Prostate 60:91-7
Gray, Danny R; Huss, Wendy J; Yau, Jeffrey M et al. (2004) Short-term human prostate primary xenografts: an in vivo model of human prostate cancer vasculature and angiogenesis. Cancer Res 64:1712-21
Kim, Desok; Gregory, Christopher W; French, Frank S et al. (2002) Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. Am J Pathol 160:219-26
Presnell, S C; Werdin, E S; Maygarden, S et al. (2001) Establishment of short-term primary human prostate xenografts for the study of prostate biology and cancer. Am J Pathol 159:855-60
Kim, D; Gregory, C W; Smith, G J et al. (1999) Immunohistochemical quantitation of androgen receptor expression using color video image analysis. Cytometry 35:2-10
Allen, M V; Smith, G J; Juliano, R et al. (1998) Downregulation of the beta4 integrin subunit in prostatic carcinoma and prostatic intraepithelial neoplasia. Hum Pathol 29:311-8
Mohler, J L; Bakewell, W E; Sharief, Y et al. (1995) Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model. Clin Exp Metastasis 13:474-80